Skip to content

Clinical trials

Phase 2 Lymphoma, Mantle-Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 2 Country / region: France Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20073
20083
20091
20111
20121
20132
20153
20161
20172
20191
20213
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting4
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Lymphoma Academic Research Organisation4
French Innovative Leukemia Organisation3
Celgene2
Eli Lilly and Company2
Institut Paoli-Calmettes2
Janssen Research & Development, LLC2
Kite, A Gilead Company2
Acerta Pharma BV1
AstraZeneca1
Cellectar Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell26
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Non-Hodgkin8
Lymphoma7
Lymphoma, Follicular7
Lymphoma, B-Cell, Marginal Zone6
Leukemia, Lymphocytic, Chronic, B-Cell4
Multiple Myeloma4
Burkitt Lymphoma3
Congenital Abnormalities3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.